Overdiagnosis and overtreatment of breast cancer: Overdiagnosis and overtreatment in service screening

Overdiagnosis and overtreatment

claim that our critique of the randomized screening trials has little merit; that there is no reason to believe that the Canadian study was of better quality than the New York Health Insurance Plan (HIP) study or the Two-County study; and that the prior consensus on mammography was correct. However, their review suffers from erroneous assumptions and biased statistical analyses, and their quota...

Overdiagnosis and overtreatment over time.

Overdiagnosis and overtreatment are often thought of as relatively recent phenomena, influenced by a contemporary combination of technology, specialization, payment models, marketing, and supply-related demand. Yet a quick glance at the historical record reveals that physicians and medical manufacturers have been accused of iatrogenic excess for centuries, if not millennia. Medicine has long ha...

Overdiagnosis and Overtreatment of Prostate Cancer and Breast Cancer Due to Screening

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

A vast range of disorders--from indolent to fast-growing lesions--are labelled as cancer. Therefore, we believe that several changes should be made to the approach to cancer screening and care, such as use of new terminology for indolent and precancerous disorders. We propose the term indolent lesion of epithelial origin, or IDLE, for those lesions (currently labelled as cancers) and their prec...

Overdiagnosis and overtreatment in cancer: an opportunity for improvement.

Over thepast 30 years, awareness and screening have led to an emphasis on early diagnosis of cancer. Althoughthegoalsof theseeffortswere to reduce the rate of late-stagediseaseanddecreasecancermortality, secular trendsandclinical trials suggest that thesegoalshave notbeenmet; national datademonstrate significant increases inearly-stagedisease,withoutaproportionaldecline in later-stagedisease.Wh...